[Efficacy and tolerability of cefixime in the treatment of otorhinolaryngeal infections in adults].

Author: BossardB, GehannoP, PeynègreR

Paper Details 
Original Abstract of the Article :
Cefixime was used in the treatment of 59 patients, 44 of whom had sinusitis, 9 otitis media and 6 various ENT infections. The clinical and bacteriological effectiveness of the drug could be evaluated in 44 patients and its safety in all 59 patients. The most common responsible pathogens were Haemoph...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/2530544

データ提供:米国国立医学図書館(NLM)

Cefixime: A Potential Treatment Option for ENT Infections

This study examines the effectiveness and safety of cefixime, a cephalosporin antibiotic, in treating otorhinolaryngeal (ENT) infections in adults. Researchers analyzed the clinical and bacteriological outcomes of 59 patients with sinusitis, otitis media, and other ENT infections who received cefixime. The study reveals that cefixime was effective in treating ENT infections, achieving clinical cure in 80% of patients. The study also found that cefixime was well tolerated, with only minor side effects reported. This research provides valuable insights into the potential use of cefixime for treating ENT infections.

Cefixime: An Effective and Well-Tolerated Treatment for ENT Infections

The study demonstrates the efficacy and tolerability of cefixime in treating ENT infections in adults. Cefixime achieved a clinical cure rate of 80%, indicating its effectiveness against common ENT pathogens such as Haemophilus influenzae, streptococci, and Enterobacteriaceae. The study also found that cefixime was well tolerated, with only minor side effects reported in a small percentage of patients. These findings suggest that cefixime could be a valuable treatment option for ENT infections.

Cefixime: A Promising Option for Managing ENT Infections

This research highlights the potential of cefixime as a safe and effective treatment for ENT infections. The study's findings, demonstrating its high cure rate and good tolerability, suggest that cefixime could be a valuable tool for managing ENT infections in adults. Further research is needed to explore its long-term efficacy and potential for wider application in treating ENT infections.

Dr.Camel's Conclusion

This research is like a desert oasis, offering a refreshing perspective on treatment options for ENT infections. Cefixime, with its effectiveness and good tolerability, could be a valuable tool for managing ENT infections, offering relief and promoting recovery for those affected.

Date :
  1. Date Completed 1989-12-21
  2. Date Revised 2016-12-09
Further Info :

Pubmed ID

2530544

DOI: Digital Object Identifier

2530544

Related Literature

SNS
PICO Info
in preparation
Languages

French

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.